Compounds > physostigmine
Page last updated: 2024-08-17

physostigmine and Muscular Weakness

physostigmine has been researched along with Muscular Weakness in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garcia, CC; Hognason, K; McArdle, JJ; Potian, JG; Routh, VH; Souayah, N; Sultatos, LG; Thyagarajan, B1
BOUDIN, G; GOULON, M; HAMBURGER, J; LAPRESLE, J; LHERMITTE, F; PEQUIGNOT, H1

Other Studies

2 other study(ies) available for physostigmine and Muscular Weakness

ArticleYear
Acetylcholinesterase deficiency contributes to neuromuscular junction dysfunction in type 1 diabetic neuropathy.
    American journal of physiology. Endocrinology and metabolism, 2012, Aug-15, Volume: 303, Issue:4

    Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuropathies; GPI-Linked Proteins; Hyperglycemia; Male; Mice; Motor Endplate; Muscle Weakness; Neuromuscular Junction Diseases; Physostigmine

2012
[HOW TO TREAT MYASTHENIA].
    La Presse medicale, 1964, Oct-10, Volume: 72

    Topics: Ambenonium Chloride; Ephedrine; Humans; Muscle Weakness; Myasthenia Gravis; Neostigmine; Physostigmine; Prognosis; Pyridostigmine Bromide; Respiratory Insufficiency; Spironolactone; Surgical Procedures, Operative; Thymus Neoplasms

1964